The recent surge in fuel prices in Pakistan has led to significant economic repercussions, notably increasing the costs of essential goods. This inflation is notably affecting the healthcare sector, where many citizens now find critical medications unaffordable. Reports from The Express Tribune indicate that the financial pressure from rising fuel costs is particularly burdensome for low- and middle-income households.

Patients with chronic illnesses are among the worst affected. The price of insulin, a vital medication for many diabetics, has reportedly increased dramatically. As a result, individuals are facing severe challenges in accessing treatments necessary for their well-being. The higher costs of medication have made it increasingly difficult for families to manage their healthcare expenses.

Significant Increase in Medication Prices

Pharmaceutical firms in Pakistan have announced unexpected price hikes for numerous essential medications, exacerbating the difficulties faced by the population. For instance, insulin prices have risen from PKR 2,200 to PKR 4,720, reflecting nearly a 100 per cent increase. Other commonly used medications have also experienced notable price surges. Acid reflux treatments have climbed from PKR 530 to PKR 620, while vitamins have jumped from PKR 480 to PKR 510. Furthermore, the cost of typhoid medications has increased from PKR 805 to PKR 930, demonstrating a troubling trend in medication affordability.

Life-critical medications, including those needed for cancer treatment and pregnancy-related conditions, have reportedly seen an increase of around PKR 400. This situation highlights the stark reality many citizens face, as they struggle to procure necessary medical treatments amidst skyrocketing costs.

Residents like Zafar Ali, a diabetic individual from Peshawar, have voiced their frustrations regarding the current economic climate. Earning a monthly salary of PKR 40,000, he remarks that the new prices for insulin have rendered it nearly unattainable. Allegations have surfaced regarding certain pharmacies deliberately creating shortages to capitalise on the situation, further complicating accessibility.

Regulatory Issues and Calls for Action

Concerns regarding the regulation of medication prices have been raised by officials within the pharmaceutical industry. Arshad Mohmand, representing the Khyber-Pakhtunkhwa Medical Drug Association, noted that the prices of vital drugs have risen between PKR 1,000 and PKR 4,000. He highlighted the lack of official price displays in many pharmacies and pointed out that some operate without the necessary licenses, attributing this to insufficient regulatory oversight.

Mohmand has advocated for stronger measures to empower the Drug Regulatory Authority of Pakistan, calling for increased inspections and penalties for those who violate existing pricing regulations. Such changes are deemed essential to ensure that essential medications remain accessible to those in need.

On the regulatory front, Abbas Khan, the Chief Drug Controller of Pakistan, clarified that medication pricing is set at the federal level under current policies. He stated that the enforcement of these prices falls under provincial jurisdiction. This division of responsibilities poses challenges in maintaining consistency in drug pricing across the country, complicating the fight against rising medication costs.

Long or Short, get news the way you like. No ads. No redirections. Download Newspin and Stay Alert, The CSR Journal Mobile app, for fast, crisp, clean updates!

App Store –  https://apps.apple.com/in/app/newspin/id6746449540 

Google Play Store – https://play.google.com/store/apps/details?id=com.inventifweb.newspin&pcampaignid=web_share